Bio Green Med Stock Analysis

Bio Stock Analysis Notes

About 68.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bio Green Med recorded a loss per share of 14.45. The entity last dividend was issued on the 1st of May 2025. The firm had 1:15 split on the 7th of July 2025. For more info on Bio Green Med please contact Sing Wong at 60 9 08517 7330 or go to https://www.bgmsglobal.com.

Bio Green Med Investment Alerts

Bio Largest EPS Surprises

View All Earnings Estimates

Bio Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.88 M.

Bio Profitablity

Management Efficiency

Bio Green Med has return on total asset (ROA) of (0.8469) % which means that it has lost $0.8469 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.7757) %, meaning that it created substantial loss on money invested by shareholders. Bio Green's management efficiency ratios could be used to measure how well Bio Green manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Bio Green's Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 6.23 in 2026, despite the fact that Return On Tangible Assets are likely to grow to (2.99). Total Assets is likely to drop to about 3.5 M in 2026. Non Current Assets Total is likely to drop to about 358.2 K in 2026

Technical Drivers

As of the 18th of February 2026, Bio Green shows the Standard Deviation of 7.71, risk adjusted performance of (0.01), and Mean Deviation of 5.39. Bio Green Med technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bio Green Med variance and potential upside to decide if Bio Green Med is priced correctly, providing market reflects its regular price of 1.03 per share. Given that Bio Green is a hitting penny stock territory we recommend to closely look at its jensen alpha.

Bio Green Med Price Movement Analysis

Bio Green Med Insider Trading Activities

Bio Green Outstanding Bonds

Bio Green Predictive Daily Indicators

Bio Green Forecast Models

Bio Green's time-series forecasting models are one of many Bio Green's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bio Green's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Bio Green Bond Ratings

Bio Green Med financial ratings play a critical role in determining how much Bio Green have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Bio Green's borrowing costs.

Bio Green Total Assets Over Time

Bio Green Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Bio Green uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Bio Green Debt Ratio

0.46

It appears most of the Bio Green's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Bio Green's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Bio Green, which in turn will lower the firm's financial flexibility.

Bio Green Corporate Bonds Issued

Bio Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bio Green prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bio shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bio Green. By using and applying Bio Stock analysis, traders can create a robust methodology for identifying Bio entry and exit points for their positions.

When running Bio Green's price analysis, check to measure Bio Green's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Green is operating at the current time. Most of Bio Green's value examination focuses on studying past and present price action to predict the probability of Bio Green's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Green's price. Additionally, you may evaluate how the addition of Bio Green to your portfolios can decrease your overall portfolio volatility.